In Response To Scorpion Capital Citizen Petition FDA Says "FDA Has Been Unable To Reach A Decision On Your Petition Because It Raises Complex Issues Requiring Extensive Review And Analysis By Agency Officials."
Portfolio Pulse from Benzinga Newsdesk
The FDA has responded to Scorpion Capital's citizen petition, stating that it has been unable to reach a decision due to the complex issues raised requiring extensive review and analysis by agency officials.
September 21, 2023 | 7:53 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
The FDA's inability to reach a decision on Scorpion Capital's petition may indirectly affect HRMY, if it is mentioned in the petition.
The news does not directly mention HRMY, but if it is mentioned in the petition, the FDA's indecision could potentially have an impact on the company. The extent of this impact is uncertain without further information.
CONFIDENCE 50
IMPORTANCE 50
RELEVANCE 50